On May 16, 2011
A Blindness Charity Wears Blinkers When It Comes to Pharma Cash and Cheap Drugs
Apart from the funding, the lobbying, the advertising and the regulatory appeals, the RNIB has absolutely no conflict of interest with Novartis on the issues of macular degeneration drugs.
No tags for this post.
0 Comments